Biotech Values

[rstor1]

Cancer stocks up across the board.

I believe that it is a combination of the OSIP news and the WSJ article on relaxed standards for approval of cancer drugs. GNTA was mentioned specifically, as well as APTH.

Lots of buzz, and with tech money looking for a new home, the stars were aligned.

Has anyone noticed that the market is very manic recently? Subsectors seem to run wild for a few days, then the market finds a new sweetheart. Just look at defense/anti-terror stocks, especially OB's, in the last few weeks.

Bob